Physician profile
Beth Ann Johnson
NPI 1023597093
$24,492.44
in general payments reported to CMS, 2019-2025
9 companies · $1,985 in 2025
The $1,985 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11K · 2022: $8,518 · 2023: $2,981 · 2024: $339 · 2025: $1,985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,930 · Travel and Lodging: $1,344 · Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,929.86 |
| Travel and Lodging | $1,344.39 |
| Food and Beverage | $1,030.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18,508.06 | 2021-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $3,660.33 | 2021 | |
| Boston Scientific Corporation | $1,636.82 | 2025 | Wavewriter Alpha Prime 16, Accolade Sr |
| Abbvie INC. | $308.42 | 2024-2025 | |
| Curonix LLC | $299.96 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $30.31 | 2024-2025 | Belbuca |
| Scilex Pharmaceuticals INC. | $18.00 | 2025 | |
| Valinor Pharma, LLC | $17.89 | 2025 | Movantik |
| Spr Therapeutics, INC | $12.65 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.